Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study.

Cuomo A, McIntyre R, Koukouna D, Pinzi M, Pardossi S, Firenzuoli B, Barillà G, Carmellini P, Alamia A, Fagiolini A

Open source

DOI
10.1177/20451253261437597
Published
2026
Container
Therapeutic advances in psychopharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/20451253261437597,
  title = {Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study.},
  author = {Cuomo A and McIntyre R and Koukouna D and Pinzi M and Pardossi S and Firenzuoli B and Barillà G and Carmellini P and Alamia A and Fagiolini A},
  year = {2026},
  journal = {Therapeutic advances in psychopharmacology},
  doi = {10.1177/20451253261437597},
  url = {https://doi.org/10.1177/20451253261437597}
}

RIS

TY  - JOUR
TI  - Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study.
AU  - Cuomo A
AU  - McIntyre R
AU  - Koukouna D
AU  - Pinzi M
AU  - Pardossi S
AU  - Firenzuoli B
AU  - Barillà G
AU  - Carmellini P
AU  - Alamia A
AU  - Fagiolini A
PY  - 2026
JO  - Therapeutic advances in psychopharmacology
DO  - 10.1177/20451253261437597
UR  - https://doi.org/10.1177/20451253261437597
ER  - 

APA

A, C., R, M., D, K., M, P., S, P., B, F., G, B., P, C., A, A., & A, F. (2026). Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study.. Therapeutic advances in psychopharmacology. https://doi.org/10.1177/20451253261437597

Source records